SIFCO Industries (NYSEAM) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Oct, 2026Executive summary
Q3 FY2026 net sales rose 18.3% to $26.1 million from $22.1 million; continuing operations recorded a $40,000 loss, or $0.01 per diluted share, versus $3.3 million income a year earlier.
Nine-month net sales increased 23.5% to $76.6 million from $62.0 million, with continuing-operations income of $4.4 million versus a $0.4 million loss.
Financial highlights
Q3 gross profit was $3.4 million versus $5.9 million; excluding the prior-year $2.4 million ERC benefit, it decreased $0.1 million YoY. Nine-month gross profit rose to $14.3 million from $8.4 million, or $8.3 million excluding that benefit.
Q3 operating profit was $286,000 versus $3.3 million; nine-month operating profit was $5.5 million versus $567,000.
Q3 EBITDA was $1.3 million versus $5.3 million, while Adjusted EBITDA was $4.8 million versus $4.4 million; nine-month EBITDA was $8.6 million versus $4.9 million and Adjusted EBITDA was $13.5 million versus $4.0 million.
Nine-month operating cash flow was $3.4 million, compared with $0.6 million used in the prior year; working-capital changes used $8.3 million, largely from higher inventory, receivables and contract assets.
Q3 discontinued-operations income was $0.0 million versus $0.1 million in Q3 FY2025.
Outlook and guidance
Strong customer demand and backlog provide visibility to future activity; focus is on converting demand into profitable growth and improving operational performance.
Backlog was $164.2 million at June 30, 2026, versus $130.4 million a year earlier; orders may be modified or canceled with limited charges, and backlog may not indicate future sales.
Remaining performance obligations totaled $164.2 million, with $99.2 million expected to be completed within 12 months.
Remaining FY2026 capital expenditures are expected to be $0.5–$0.7 million, principally for production and product capability enhancements and operating cost reductions.
Existing cash and available credit lines are expected to fund operations and planned capital expenditures for the next 12 months; operating cash flows are expected to support longer-term liquidity needs.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - H1 sales rose 10.9%, losses narrowed, and backlog reached $129.2M.NYSEAM
Q2 2025 - Q3 growth lifted earnings, but October debt maturity leaves refinancing risk unresolved.NYSEAM
Q3 2024 - Higher military volumes and pricing drove a sharp return to profit, with financing and environmental risks persisting.NYSEAM
Q2 2026 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - ERC benefits and aerospace demand lifted Q3 profit; backlog stood at $130.4M.NYSEAM
Q3 2025 - Four directors, auditor ratification and a pause in FY2025 long-term awards headline the proxy.NYSEAM
Proxy filing - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026